Clinical Trials in Phoenix

Showing 6941-6960 of 16,646 trials

Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote

NCT03218241

This is a single center, double-blind, randomized, placebo-controlled, ascending, single dose study of PRT064445 or its matching placebo, in healthy subjects.

Healthy

Portola Pharmaceuticals32 participantsStarted Jun 2012

Phoenix, Arizona, United States

COMPLETEDNA< 1 mile

Look AHEAD: Action for Health in Diabetes

NCT00017953

The Look AHEAD study is a multi-center, randomized clinical trial to examine the long-term effects of a lifestyle intervention designed to achieve and maintain weight loss. The study will investigate the effects of the intervention on heart attacks, stroke and cardiovascular-related death in individuals with type 2 diabetes who are also overweight or obese.

DiabetesMyocardial InfarctionStroke+3 more

Wake Forest University Health Sciences5,145 participantsStarted Jun 2001

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +15 more locations

Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote

Look AHEAD: Action for Health in Diabetes

Find Trials by Condition in Phoenix

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Decision Aids to Improve Knowledge in Patients With Prostate Cancer

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

A Study of CIN-107 in Patients With Uncontrolled Hypertension

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Zalutumumab in Non-curable Patients With SCCHN

A Study of PRN1008 in Patients With Pemphigus

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Family Health History in Diverse Care Settings (FHH)

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer